XERIS BIOPHARMA HOLDINGS, INC. Shares Issued, Price Per Share
XERIS BIOPHARMA HOLDINGS, INC. (XERS) had Shares Issued, Price Per Share of $4.12 per share as of 2021-03-17, per its 10-K filed 2023-03-08.
Discontinued › Notes › Equity
us-gaap:SharesIssuedPricePerShare · last filed 2023-03-08
- 2021-03-17: Shares Issued, Price Per Share $4.12.
- 2020-07-15: Shares Issued, Price Per Share $2.72.
- 2020-02-14: Shares Issued, Price Per Share $4.15.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2021-03-17 | $4.12 10-K · filed 2023-03-08 |
| 2020-07-15 | $2.72 10-K · filed 2022-03-11 |
| 2020-02-14 | $4.15 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |